Granules India Limited
NSE: GRANULES BSE: GRANULES
NSE
480.20
12.70 (2.72%)
Prev Close
467.5
Open Price
474
Volume
1,207,487
Today Low / High
468.3 / 483.85
52 WK Low / High
389.35 / 721
Range
456 - 504
BSE
480.45
13.05 (2.79%)
Prev Close
467.4
Open Price
473.6
Volume
18,130
Today Low / High
469.5 / 483.2
52 WK Low / High
389.15 / 724.55
Range
456 - 504
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 480.2 (target range: 456 - 504), reflecting a change of 12.7 (2.71658%). On the BSE, it is listed at 480.45 (target range: 456 - 504), showing a change of 13.05 (2.79204%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
21 Apr
474.00
1.31%
17 Apr
462.00
1.19%
16 Apr
465.00
-0.42%
15 Apr
457.90
1.42%
11 Apr
442.20
2.06%
09 Apr
436.00
-1.12%
08 Apr
447.00
-0.59%
07 Apr
440.90
-0.91%
04 Apr
494.10
-7.56%
03 Apr
492.00
-0.16%
02 Apr
488.00
-0.99%
01 Apr
488.00
-1.08%
28 Mar
490.50
-0.85%
27 Mar
492.00
-0.33%
26 Mar
505.10
-2.50%
25 Mar
514.95
-1.91%
24 Mar
510.05
0.27%
Granules India Limited Graph
Granules India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Granules India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 480.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 480.45 | 485.25 | 436.73 - 533.78 |
| 490.06 | 392.05 - 588.07 | ||
| 494.86 | 346.40 - 643.32 | ||
| Bearish Scenario | 480.45 | 475.65 | 428.08 - 523.21 |
| 470.84 | 376.67 - 565.01 | ||
| 466.04 | 326.23 - 605.85 |
Overview of Granules India Limited
ISIN
INE101D01020
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
1,286,571
Market Cap
116,469,494,344
Last Dividend
1.5
Official Website
IPO Date
2005-06-20
DCF Diff
-301.28
DCF
781
Financial Ratios Every Investor Needs
Stock Dividend of GRANULES
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-07-30 | July 30, 24 | 1.5 | 1.5 | 2024-07-30 | 2024-09-05 | |
| 2023-08-03 | August 03, 23 | 1.5 | 1.5 | 2023-08-03 | 2023-09-08 | |
| 2022-07-19 | July 19, 22 | 0.75 | 0.75 | 2022-07-20 | 2022-08-25 | |
| 2022-02-17 | February 17, 22 | 0.25 | 0.25 | 2022-02-18 | 2022-03-10 | |
| 2021-11-24 | November 24, 21 | 0.25 | 0.25 | 2021-11-25 | 2021-12-12 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 4,506.37 Cr | 2,130.71 Cr | 2,375.66 Cr | 0.5272 | 198.56 Cr | 85.13 Cr | 652.83 Cr | 405.31 Cr | 16.73 | 826.32 Cr | 0.0899 |
| 2023-03-31 | 4,511.92 Cr | 2,307.29 Cr | 2,204.63 Cr | 0.4886 | 116.38 Cr | 73.88 Cr | 782.04 Cr | 516.60 Cr | 21.05 | 927.60 Cr | 0.1145 |
| 2022-03-31 | 3,727.17 Cr | 1,958.90 Cr | 1,768.27 Cr | 0.4744 | 142.96 Cr | 51.44 Cr | 574.62 Cr | 412.76 Cr | 16.65 | 739.84 Cr | 0.1107 |
| 2021-03-31 | 3,196.03 Cr | 1,455.00 Cr | 1,741.03 Cr | 0.5447 | 100.16 Cr | 37.56 Cr | 727.57 Cr | 549.46 Cr | 22.05 | 882.11 Cr | 0.1719 |
| 2020-03-31 | 2,545.24 Cr | 1,315.56 Cr | 1,229.68 Cr | 0.4831 | 78.91 Cr | 33.98 Cr | 481.31 Cr | 335.40 Cr | 13.19 | 589.61 Cr | 0.1318 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 381.10 Cr | 5,520.98 Cr | 2,295.44 Cr | 3,225.5440 Cr | 1,315.06 Cr | 933.96 Cr | 1,300.55 Cr | 2,259.78 Cr | 17.84 Cr | 0.00 Cr | 21.52 Cr | 2,082.2930 Cr |
| 2023-03-31 | 291.56 Cr | 4,904.56 Cr | 2,069.66 Cr | 2,834.9090 Cr | 1,136.24 Cr | 844.68 Cr | 1,149.41 Cr | 1,859.36 Cr | 6.40 Cr | 0.00 Cr | 11.66 Cr | 1,813.5010 Cr |
| 2022-03-31 | 184.71 Cr | 4,512.90 Cr | 1,925.81 Cr | 2,586.5329 Cr | 1,106.31 Cr | 921.60 Cr | 978.55 Cr | 1,595.64 Cr | 6.61 Cr | 0.00 Cr | -195.04 Cr | 1,641.6000 Cr |
| 2021-03-31 | 41.84 Cr | 3,713.45 Cr | 1,540.18 Cr | 2,173.2743 Cr | 849.21 Cr | 807.37 Cr | 782.18 Cr | 1,255.99 Cr | 117.07 Cr | 0.00 Cr | -202.43 Cr | 1,173.0981 Cr |
| 2020-03-31 | 185.93 Cr | 3,301.50 Cr | 1,457.78 Cr | 1,843.7241 Cr | 892.10 Cr | 706.17 Cr | 438.43 Cr | 1,136.84 Cr | 61.01 Cr | 0.00 Cr | -32.60 Cr | 966.5405 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 439.4140 Cr | -360.1600 Cr | 7.6640 Cr | 58.8380 Cr | 89.5430 Cr | 381.1000 Cr | -380.5760 Cr | 405.3100 Cr | 154.7780 Cr | -36.3060 Cr | -140.7300 Cr |
| 2023-03-31 | 663.6780 Cr | -96.4520 Cr | -519.4700 Cr | 451.8850 Cr | 47.5030 Cr | 181.7460 Cr | -211.7930 Cr | 663.9400 Cr | -47.0920 Cr | -18.6220 Cr | -2.6700 Cr |
| 2022-03-31 | 332.0541 Cr | -380.1149 Cr | 189.9971 Cr | -65.6528 Cr | 142.8775 Cr | 184.7134 Cr | -397.7069 Cr | 557.9983 Cr | 253.0410 Cr | -37.1713 Cr | -184.0266 Cr |
| 2021-03-31 | 432.4778 Cr | -277.1350 Cr | -299.3131 Cr | 161.1362 Cr | -144.0930 Cr | 41.8359 Cr | -271.3416 Cr | 704.3643 Cr | -71.9332 Cr | -24.7208 Cr | -345.8876 Cr |
| 2020-03-31 | 476.1884 Cr | -160.6331 Cr | -212.8550 Cr | 291.7094 Cr | 102.9046 Cr | 185.9289 Cr | -184.4790 Cr | 425.6352 Cr | -153.3990 Cr | -30.6509 Cr | -54.2183 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,133.52 Cr | 435.68 Cr | 697.84 Cr | 0.6156 | 173.68 Cr | 117.60 Cr | 4.85 | 235.97 Cr | 0.1038 |
| 2024-09-30 | 956.52 Cr | 367.21 Cr | 589.32 Cr | 0.6161 | 150.80 Cr | 97.23 Cr | 4.01 | 206.57 Cr | 0.1017 |
| 2024-06-30 | 1,179.87 Cr | 700.92 Cr | 478.95 Cr | 0.4059 | 206.40 Cr | 134.65 Cr | 5.56 | 261.33 Cr | 0.1141 |
| 2024-03-31 | 1,175.78 Cr | 674.48 Cr | 501.30 Cr | 0.4264 | 202.53 Cr | 129.65 Cr | 5.35 | 257.58 Cr | 0.1103 |
| 2023-12-31 | 1,155.58 Cr | 497.33 Cr | 658.25 Cr | 0.5696 | 198.74 Cr | 125.65 Cr | 5.18 | 251.13 Cr | 0.1087 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 208.85 Cr | 9.71 Cr | 218.56 Cr | 0.00 Cr | 1,395.44 Cr | 2,605.34 Cr | 2,304.37 Cr | 5,432.70 Cr | 2,005.47 Cr |
| 2024-06-30 | -381.10 Cr | 762.20 Cr | 381.10 Cr | 0.00 Cr | 0.00 Cr | 381.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 386.39 Cr | 8.19 Cr | 386.39 Cr | 1,001.88 Cr | 1,300.55 Cr | 2,905.05 Cr | 2,115.63 Cr | 5,520.98 Cr | 2,295.44 Cr |
| 2023-12-31 | -311.91 Cr | 623.81 Cr | 311.91 Cr | 0.00 Cr | 0.00 Cr | 311.91 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 295.50 Cr | 18.66 Cr | 314.16 Cr | 1,015.73 Cr | 1,279.61 Cr | 2,792.31 Cr | 2,006.52 Cr | 5,264.85 Cr | 2,297.44 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 134.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 129.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 125.65 Cr | 104.78 Cr | 0.00 Cr | 0.00 Cr | 104.78 Cr | 416.69 Cr | 311.91 Cr | 0.00 Cr | 104.78 Cr |
| 2023-09-30 | 102.12 Cr | 105.05 Cr | 0.00 Cr | 0.00 Cr | 105.05 Cr | 311.91 Cr | 206.86 Cr | 0.00 Cr | 105.05 Cr |
| 2023-06-30 | 47.90 Cr | 98.48 Cr | 0.00 Cr | 0.00 Cr | 98.48 Cr | 411.27 Cr | 312.79 Cr | 0.00 Cr | 98.48 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2015-03-23 | March 23, 15 | 10:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,744.90 | ₹4,186,497,390,360.00 | ₹1,539,404.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,891.50 | ₹1,564,008,080,155.00 | ₹717,304.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,254.60 | ₹1,101,504,496,478.00 | ₹168,941.00 |
| Mankind Pharma Limited | MANKIND | ₹2,588.40 | ₹1,067,918,241,168.00 | ₹342,053.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,177.40 | ₹980,907,622,968.00 | ₹1,938,682.00 |
| Lupin Limited | LUPIN | ₹2,009.20 | ₹917,330,458,276.00 | ₹966,589.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹845.35 | ₹850,616,530,500.00 | ₹1,860,605.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,201.20 | ₹697,658,929,968.00 | ₹653,310.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,000.40 | ₹597,872,826,000.00 | ₹97,948.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,368.80 | ₹386,259,126,032.00 | ₹2,163,260.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,423.80 | ₹361,224,068,436.00 | ₹163,712.00 |
| Laurus Labs Limited | LAURUSLABS | ₹640.35 | ₹345,310,338,375.00 | ₹1,671,228.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,679.20 | ₹334,664,498,320.00 | ₹44,703.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,202.20 | ₹306,037,994,912.00 | ₹330,131.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,658.70 | ₹258,221,804,814.00 | ₹100,079.00 |
| Piramal Enterprises Limited | PEL | ₹1,039.85 | ₹234,462,986,345.00 | ₹552,041.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,401.40 | ₹227,698,028,558.00 | ₹264,593.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,727.50 | ₹218,187,500,000.00 | ₹13,476.00 |
| Eris Lifesciences Limited | ERIS | ₹1,382.90 | ₹188,299,218,053.00 | ₹81,150.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,136.00 | ₹168,533,566,400.00 | ₹53,273.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹849.65 | ₹167,009,863,405.00 | ₹223,768.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹829.80 | ₹148,625,361,828.00 | ₹383,129.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹915.95 | ₹145,893,560,183.00 | ₹228,298.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,906.70 | ₹144,931,500,763.00 | ₹146,966.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹480.20 | ₹116,469,494,344.00 | ₹1,207,487.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,223.50 | ₹86,706,866,654.00 | ₹3,571.00 |
| FDC Limited | FDC | ₹430.60 | ₹70,106,024,754.00 | ₹67,489.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹712.85 | ₹64,608,888,867.00 | ₹374,808.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹658.10 | ₹64,356,197,871.00 | ₹163,074.00 |
| Strides Pharma Science Limited | STAR | ₹640.75 | ₹59,053,256,433.00 | ₹243,236.00 |
| Innova Captab Limited | INNOVACAP | ₹915.85 | ₹52,409,452,141.00 | ₹37,786.00 |
| Hikal Limited | HIKAL | ₹423.80 | ₹52,254,857,850.00 | ₹371,223.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹152.84 | ₹49,599,942,480.00 | ₹505,473.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹633.90 | ₹44,630,236,620.00 | ₹75,809.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹799.75 | ₹40,562,604,224.00 | ₹101,985.00 |
| Sequent Scientific Limited | SEQUENT | ₹148.17 | ₹37,087,247,340.00 | ₹527,793.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,179.20 | ₹36,041,821,488.00 | ₹10,217.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹349.90 | ₹35,087,098,650.00 | ₹40,163.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹361.65 | ₹33,007,795,500.00 | ₹101,872.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹53.91 | ₹29,540,183,967.00 | ₹4,747,370.00 |
| Suven Life Sciences Limited | SUVEN | ₹127.13 | ₹27,723,712,024.00 | ₹173,057.00 |
| Alembic Limited | ALEMBICLTD | ₹105.35 | ₹27,051,965,791.00 | ₹436,085.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹520.70 | ₹25,021,207,514.00 | ₹37,558.00 |
Key Executives
Chief Financial Officer
Mr. Mukesh Surana
Gender: male
Year Born: 1981
Chairman & MD
Dr. Krishna Prasad Chigurupati B.Sc.
Gender: Not Specified
Year Born: 1954
Company Secretary & Compliance Officer
Ms. Chaitanya Tummala
Gender: female
Year Born:
Chief Human Resources Officer
Mr. Atul Dhavle B.E.
Gender: male
Year Born: 1970
Chief Technology Officer
Dr. P. V. Srinivas
Gender: Not Specified
Year Born: 1966
Joint MD, Chief Executive Officer & Additional Director
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
Gender: Not Specified
Year Born: 1963
Whole-Time Director
Ms. Priyanka Chigurupati
Gender: female
Year Born:
Executive Director
Mr. Harsha Chigurupati BBA
Gender: male
Year Born: 1983
President and Chief Strategy & Sustainability Officer
Mr. Sanjay Kumar
Gender: male
Year Born:
President & Head - Formulations Operations
Mr. Ramraj Rangarajulu
Gender: male
Year Born:
FAQs about Granules India Limited
Who is the CEO of the company?
The CEO is Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D..
What is the current market price of the stock?
The current price is ₹480.20.
What is the 52-week price range?
The range is ₹389.35-721.
What is the market capitalization of the company?
The market capitalization is ₹11,646.95 crores.
What is the dividend yield?
The dividend yield is 0.31%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 24.30.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Granules India Limited (ISIN: INE101D01020) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹11,646.95 crores and an average daily volume of 1,286,571 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.5.